SCHEMBL8066751

SCHEMBL8066751

Cc1ccc(NCCc2c[nH]c3c(C)cccc23)c(C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.55
MAPT P10636 5/20 0.53
NPSR1 Q6W5P4 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
ATM Q13315 1/20 0.46
SOS2 Q07890 1/20 0.46
NR3C1 P04150 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HTT P42858 1/20 0.46
PGR P06401 1/20 0.43
NR3C2 P08235 1/20 0.43
PCSK9 Q8NBP7 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
PTGS2 P35354 2/20 0.41
PTGS1 P23219 1/20 0.41
CRHBP P24387 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8048114 0.88 HTR2A (0.59) HTR2AMAPTNPSR1SMN1; SMN2ALDH1A1
SCHEMBL12811112 0.86 HTR2A (0.51) HTR2AMAPTNPSR1SMN1; SMN2ALDH1A1
SCHEMBL8065759 0.86 HTR2A (0.51) HTR2AMAPTNPSR1SMN1; SMN2ALDH1A1
SCHEMBL15267556 0.85 ALDH1A1 (0.47) HTR2AMAPTNPSR1SMN1; SMN2ALDH1A1
SCHEMBL8063649 0.84 HTR2A (0.49) HTR2AMAPTNPSR1SMN1; SMN2ALDH1A1
SCHEMBL15267545 0.83 ALDH1A1 (0.45) HTR2AMAPTNPSR1SMN1; SMN2ALDH1A1
SCHEMBL8265777 0.83 ALDH1A1 (0.69) HTR2AMAPTNPSR1ALDH1A1NPC1
SCHEMBL18784114 0.83 HTR2A (0.56) HTR2AMAPTNPSR1SMN1; SMN2ALDH1A1
SCHEMBL8043018 0.83 MAPT (0.64) HTR2AMAPTNPSR1SMN1; SMN2ALDH1A1
SCHEMBL8044595 0.81 HTR2A (0.53) HTR2AMAPTNPSR1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853406-B2 Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53 JANSSEN PHARMACEUTICA NV (BE) 2014-10-07 US disclosed
WO-2009019274-A1 SUBSTITUTED PHENYLENEDIAMINES AS INHIBITORS OF THE INTERACTION BETWEEN MDM2 AND P53 JANSSEN PHARMACEUTICA NV (BE) 2009-02-12 WO disclosed